Proteus 235 and Proteus ONE proton therapy systems
Recall is being initiated to address on-site software installations not being performed consistently with IBA standard operating procedures.
Products distributed to FL, VA, PA, OK, IL, NJ, WA, TN, LA, TX, South Korea, Germany, France, Czech Republic, Italy, Poland, and Sweden
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2672-2017